Abstract
Recognition of cutaneous side effects of bleomycin, a commonly used chemotherapeutic agent, is important to avoid unnecessary discontinuation of therapy. Here, we present the case of a 15-year-old boy who was undergoing treatment with standard BEP (bleomycin, etoposide, and cisplatin) regime, presented with flagellate hyperpigmented lesions in the back, arm, and thighs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: Indian Journal of Case Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
